Cargando…
A verification of the application of the non-derivatized mass spectrometry method in newborns screening of metabolic disorders
It is required that the clinical screening of metabolic disorders in newborns meet International Organization for Standardization 15189-2012 approval. The new tandem mass spectrometry (MS/MS) based screening system and its companion reagent should be independently authenticated before their implemen...
Autores principales: | Zheng, Yulan, Chen, Yao, Qiu, Xiaolong, Chen, Weifen, Lin, Qingying, Zeng, Yinglin, Zhao, Hong, Zhu, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531236/ https://www.ncbi.nlm.nih.gov/pubmed/31083189 http://dx.doi.org/10.1097/MD.0000000000015500 |
Ejemplares similares
-
Non-derivatizing Tandem Mass Spectrometry Assay for Expanded Newborn Screening and Cutoffs for Preterm Neonates
por: Lee, Joon Hee, et al.
Publicado: (2023) -
Gene spectrum and clinical traits of 10 patients with primary carnitine deficiency
por: Chen, Yao, et al.
Publicado: (2021) -
On‐tissue chemical derivatization in mass spectrometry imaging
por: Harkin, Carla, et al.
Publicado: (2021) -
Sialic acid derivatization for glycan analysis by mass spectrometry
por: NISHIKAZE, Takashi
Publicado: (2019) -
Gene diagnosis and pedigree analysis of two Han ethnicity families with propionic acidemia in Fujian
por: Chen, Yao, et al.
Publicado: (2021)